IDH3A and central nervous system cancer: We previously reported on the diagnostic performance of 18F-FDOPA for the molecular characterization of newly diagnosed gliomas in a radiomics study which measured the contributions of dynamic acquisition and radiomics features to identify the molecular parameters of isocitrate dehydrogenase (IDH) mutation and/or 1p/19q codeletion [9].